V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196755 | 20152562 | 1.36 | 74.9 | null | 2015-11-21 | 2018-03-02 | Docetaxel | 02 | null | DOCETAXEL | 101148845 |
| 20196756 | 20152563 | 1.85 | 89 | Palliative (P) | 2016-10-08 | 2016-10-09 | Docetaxel | 02 | N | DOCETAXEL | 101727882 |
| 20196759 | 20152564 | 1.6 | 70.3 | null | 2019-06-14 | 2019-06-27 | Docetaxel | 02 | null | DOCETAXEL | 100480317 |
| 20196780 | 20152565 | 1.68 | 79.8 | Palliative (P) | 2018-12-15 | 2018-12-15 | Docetaxel | 02 | N | DOCETAXEL | 100208914 |
| 20196781 | 20152566 | 1.84 | 82.6 | Adjuvant (A) | 2018-07-09 | 2018-07-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100832954 |
| 20196788 | 20152567 | 1.85 | 81.15 | Palliative (P) | 2021-06-11 | 2021-06-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100678499 |
| 20196790 | 20152568 | 1.69 | 85 | Palliative (P) | 2018-07-15 | 2018-11-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101810227 |
| 20196791 | 20152569 | 1.59 | 59 | Palliative (P) | 2016-05-06 | 2019-01-21 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101076890 |
| 20196797 | 20152570 | 1.63 | 88.3 | Palliative (P) | 2014-08-21 | 2017-02-16 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100771656 |
| 20196799 | 20152571 | 1.76 | 79.6 | Palliative (P) | 2017-11-05 | 2017-11-07 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100292189 |
| 20196804 | 20152572 | 1.59 | 59.7 | Palliative (P) | 2020-01-15 | 2020-01-23 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101407821 |
| 20196819 | 20152573 | 1.7 | 83.9 | Palliative (P) | 2018-09-30 | 2018-10-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101230729 |
| 20196822 | 20152574 | 1.75 | 122 | null | 2019-11-13 | 2019-11-23 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101636387 |
| 20196827 | 20152575 | 1.83 | 100.3 | Palliative (P) | 2017-05-02 | 2017-09-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101835550 |
| 20196829 | 20152576 | 1.52 | 86.3 | Palliative (P) | 2019-08-02 | 2019-12-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100772410 |
| 20196830 | 20152577 | 1.54 | 95 | Neo-adjuvant (N) | null | 2017-02-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100142282 |
| 20196831 | 20152578 | 1.52 | 70.75 | Palliative (P) | 2017-06-14 | 2017-06-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101302067 |
| 20196836 | 20152579 | 1.7 | 51.1 | null | 2018-07-21 | 2019-01-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101343172 |
| 20196841 | 20152580 | 1.67 | 79 | null | 2019-01-09 | 2019-01-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100099547 |
| 20196842 | 20152581 | 1.7 | 72 | null | 2019-01-22 | 2019-04-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100711354 |
| 20196843 | 20152582 | 1.52 | 61.2 | Neo-adjuvant (N) | 2019-04-25 | 2019-05-11 | CETUXIMAB + IRINOTECAN + MDG | null | N | CAPECITABINE + GEMCITABINE | 100619600 |
| 20196844 | 20152583 | 1.78 | 87.4 | null | 2020-03-17 | 2020-03-24 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 100677715 |
| 20196847 | 20152584 | 1.81 | 78 | Palliative (P) | 2017-05-28 | 2017-06-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101506116 |
| 20196852 | 20152585 | 1.66 | 113.2 | Palliative (P) | 2016-04-24 | 2016-05-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | Y | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101036041 |
| 20196853 | 20152586 | 1.84 | 59.8 | null | 2017-10-07 | 2017-10-09 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101248293 |
| 20196859 | 20152587 | 0 | 79 | null | 2020-10-01 | 2020-10-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100246141 |
| 20196863 | 20152588 | 1.67 | 48 | Palliative (P) | 2019-02-10 | 2019-02-10 | Docetaxel | 02 | N | DOCETAXEL | 100475408 |
| 20196866 | 20152589 | 1.53 | 64.4 | Palliative (P) | 2019-05-21 | 2019-09-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100331604 |
| 20196867 | 20152590 | 1.83 | 70 | Palliative (P) | 2017-03-28 | 2017-04-03 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101137947 |
| 20196870 | 20152591 | 1.66 | 101.6 | Adjuvant (A) | 2018-09-09 | 2018-09-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100678375 |
| 20196873 | 20152592 | 2 | 95.4 | null | 2019-01-30 | 2020-01-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 100152753 |
| 20196874 | 20152593 | 1.44 | 56.8 | null | 2017-12-08 | 2017-12-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100435828 |
| 20196875 | 20152594 | 1.68 | 59.8 | null | 2020-07-19 | 2020-07-19 | Docetaxel | 02 | null | DOCETAXEL | 100574647 |
| 20196881 | 20152595 | 1.52 | 74.8 | null | 2021-10-14 | 2021-10-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100860788 |
| 20196884 | 20152596 | 1.9 | 64.5 | Palliative (P) | 2020-09-21 | 2020-09-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100666472 |
| 20196885 | 20152597 | 1.6 | 62.3 | Neo-adjuvant (N) | 2017-09-18 | 2017-10-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100913683 |
| 20196921 | 20152598 | 1.54 | 78 | Palliative (P) | 2022-02-18 | 2022-03-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101184257 |
| 20196922 | 20152599 | 1.69 | 88 | Palliative (P) | 2018-07-09 | 2018-07-31 | Docetaxel | 02 | N | DOCETAXEL | 100859930 |
| 20196927 | 20152600 | 1.84 | 60 | Palliative (P) | 2018-07-11 | 2018-11-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101819281 |
| 20196929 | 20152601 | 1.64 | 62 | Palliative (P) | 2019-05-04 | 2019-05-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 100103581 |
| 20196930 | 20152602 | 1.81 | 50.6 | null | 2017-08-19 | 2017-08-27 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100790336 |
| 20196931 | 20152603 | 1.83 | 129.1 | Palliative (P) | 2020-04-24 | 2020-05-11 | Docetaxel | 02 | N | DOCETAXEL | 101682139 |
| 20196933 | 20152604 | 1.66 | 63 | null | 2019-05-28 | 2019-06-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101693589 |
| 20196934 | 20152605 | 1.85 | 82.8 | Palliative (P) | 2018-12-30 | 2019-01-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101665273 |
| 20196936 | 20152606 | 1.7 | 59 | 03 | 2018-09-28 | 2018-10-07 | Docetaxel | 02 | N | DOCETAXEL | 100865196 |
| 20196939 | 20152607 | 1.7 | 67.2 | null | 2019-09-23 | 2019-09-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100284574 |
| 20196949 | 20152608 | 1.74 | 65.5 | Palliative (P) | 2019-04-30 | 2019-04-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100954116 |
| 20196958 | 20152609 | 1.66 | 65.5 | Palliative (P) | 2016-02-23 | 2016-08-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101149968 |
| 20196969 | 20152610 | 1.81 | 78.3 | Palliative (P) | 2018-12-04 | 2019-01-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100956813 |
| 20196974 | 20152611 | 1.78 | 69.8 | Palliative (P) | 2018-08-24 | 2018-09-01 | Docetaxel | 02 | N | DOCETAXEL | 101660556 |